Search
Skip to Search Results- 1Betageri, Gurupadappa.
- 1Da Silveira Cavalcante, Luciana
- 1Dong, Cunji.
- 1Fan, Chris Zhiming.
- 1Field, Catherine Jane
- 1Fitzsimmons, Ross
- 4Faculty of Pharmacy and Pharmaceutical Sciences
- 2Department of Pharmacy and Pharmaceutical Sciences
- 1Department of Agricultural, Food, and Nutritional Science
- 1Department of Biochemistry
- 1Department of Biological Sciences
- 1Department of Biomedical Engineering
- 1Acker, Jason (Laboratory Medicine and Pathology)
- 1Holovati, Jelena (Laboratory Medicine and Pathology)
- 1Keelan, Monika (Laboratory Medicine and Pathology)
- 1Lavasanifar, Afsaneh (Faculty of Pharmacy and Pharmaceutical Sciences)
- 1Temelli, Feral (Agricultural, Food and Nutritional Science)
- 1Uludag, Hasan (Chemical and Materials Engineering)
-
Spring 2011
The objective of this thesis is to design nanoparticle (NP)-based drug delivery systems suitable for treatment of bone diseases. Two types of nanocarriers, (1) polymer coated bovine serum albumin (BSA) NPs and (2) lipid based NPs (micelles and liposomes) were investigated. The BSA NPs were...
-
Development of polymer and lipid based nano-delivery systems for targeted cancer chemotherapy
DownloadFall 2012
Conventional chemotherapy agents can kill tumor cells and inhibit tumor growth, but they produce severe side effects on normal cells at the same time. To shift the balance towards tumoral effects, it would be desirable to direct the anti-cancer drug towards tumor while restricting drug access to...
-
Liposome-based therapy: An alternative approach to treat Helicobacter pylori infection in high prevalence communities such as Aklavik, NWT
DownloadSpring 2016
Helicobacter pylori infects about half of the world population causing chronic gastritis, peptic ulcer or gastric cancer. The Aboriginal people in Aklavik, NWT, Canada are concerned about gastric cancer because of the high prevalence of H. pylori infection (58%) in their community. H. pylori...
-
Spring 2012
The following thesis describes original studies assessing the gene delivery efficacy of novel non-viral carrier combinations. The first panel of non-viral carriers tested are termed AVPs (artificial viral particles), in reference to their structural similarity to enveloped viruses, and were...